PURE Bioscience, Inc. (PURE)
OTCMKTS: PURE · Delayed Price · USD
0.0680
+0.0060 (9.68%)
Jul 2, 2024, 9:53 AM EDT - Market closed
PURE Bioscience Revenue
PURE Bioscience had revenue of $2.09M in the twelve months ending April 30, 2024, with 23.95% growth year-over-year. Revenue in the quarter ending April 30, 2024 was $441.00K with 8.35% year-over-year growth. In the fiscal year ending July 31, 2023, PURE Bioscience had annual revenue of $1.88M with 1.30% growth.
Revenue (ttm)
$2.09M
Revenue Growth
+23.95%
P/S Ratio
3.64
Revenue / Employee
$190,091
Employees
11
Market Cap
7.61M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2023 | 1.88M | 24.00K | 1.30% |
Jul 31, 2022 | 1.85M | -2.07M | -52.81% |
Jul 31, 2021 | 3.93M | -2.99M | -43.23% |
Jul 31, 2020 | 6.92M | 5.01M | 262.34% |
Jul 31, 2019 | 1.91M | 135.00K | 7.61% |
Jul 31, 2018 | 1.77M | -57.00K | -3.11% |
Jul 31, 2017 | 1.83M | 542.00K | 42.05% |
Jul 31, 2016 | 1.29M | 560.00K | 76.82% |
Jul 31, 2015 | 729.00K | 179.00K | 32.55% |
Jul 31, 2014 | 550.00K | -270.00K | -32.93% |
Jul 31, 2013 | 820.00K | 8.00K | 0.99% |
Jul 31, 2012 | 812.00K | 347.82K | 74.93% |
Jul 31, 2011 | 464.18K | -971.96K | -67.68% |
Jul 31, 2010 | 1.44M | 707.87K | 97.20% |
Jul 31, 2009 | 728.26K | -759.20K | -51.04% |
Jul 31, 2008 | 1.49M | 1.15M | 342.18% |
Jul 31, 2007 | 336.39K | 135.96K | 67.83% |
Jul 31, 2006 | 200.43K | 44.63K | 28.64% |
Jul 31, 2005 | 155.81K | -107.69K | -40.87% |
Jul 31, 2004 | 263.50K | -2.33M | -89.82% |
Jul 31, 2003 | 2.59M | -616.95K | -19.24% |
Jul 31, 2002 | 3.21M | 796.73K | 33.06% |
Jul 31, 2001 | 2.41M | 748.26K | 45.04% |
Jul 31, 2000 | 1.66M | -1.74M | -51.13% |
Jul 31, 1999 | 3.40M | 1.70M | 100.00% |
Jul 31, 1998 | 1.70M | 700.00K | 70.00% |
Jul 31, 1997 | 1.00M | 200.00K | 25.00% |
Jul 31, 1996 | 800.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 657.33B |
Costco | 253.70B |
PepsiCo | 91.88B |
Procter & Gamble | 84.06B |
Unilever | 66.23B |
Anheuser-Busch InBev | 59.38B |
The Coca-Cola Company | 46.07B |
Mondelez International | 36.14B |
PURE News
- 16 hours ago - PURE Bioscience to Unveil its Newest Food Safety Solutions at the Annual International Association for Food Protection Meeting - Business Wire
- 14 days ago - PURE Bioscience Announces an International Supply and License Agreement with AgroVet Alliance - Business Wire
- 18 days ago - PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results - Business Wire
- 2 months ago - PURE Bioscience Appoints Darin Zehr to Board of Directors - Business Wire
- 3 months ago - PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results - Business Wire
- 7 months ago - PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results - Business Wire
- 8 months ago - PURE Bioscience Reports Fiscal 2023 Financial Results - Business Wire
- 1 year ago - PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting - Business Wire